DIPESH RANA: Open Payments
NPI 1477827087 · GARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 42 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $900
Food & beverage: $900
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $325 |
| Otsuka America Pharmaceutical, Inc. | 8 | $168 |
| Dexcom, Inc. | 3 | $61 |
| Exact Sciences Corporation | 2 | $57 |
| ABBVIE INC. | 3 | $52 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Amgen Inc. | 2 | $39 |
| Lilly USA, LLC | 2 | $31 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
Products named: AIRSUPRA, REXULTI, FARXIGA, Dexcom G6 Transmitter, Cologuard Collection Kit, REPATHA, BREZTRI, MOUNJARO.
Industry payments across TX — which companies pay providers there.
